123 related articles for article (PubMed ID: 17963631)
1. [The white coat effect during the first hour of ambulatory blood pressure].
Huang JF; Cao J; Li JX; Wang LX
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Aug; 35(8):723-6. PubMed ID: 17963631
[TBL] [Abstract][Full Text] [Related]
2. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
3. Elevated blood pressure during the first two hours of ambulatory blood pressure monitoring: a study comparing consecutive twenty-four-hour monitoring periods.
Prasad N; MacFadyen RJ; Ogston SA; MacDonald TM
J Hypertens; 1995 Mar; 13(3):291-5. PubMed ID: 7622849
[TBL] [Abstract][Full Text] [Related]
4. Detecting white coat and reverse white coat effects in clinic settings using measures of blood pressure habituation in the clinic and patient self-monitoring of blood pressure.
Larkin KT; Schauss SL; Elnicki DM; Goodie JL
J Hum Hypertens; 2007 Jul; 21(7):516-24. PubMed ID: 17361194
[TBL] [Abstract][Full Text] [Related]
5. White coat effect--problem of assessing its incidence and magnitude in children.
Pijanowska M; Zajaczkowska M; Pijanowski Z
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):367-71. PubMed ID: 15315017
[TBL] [Abstract][Full Text] [Related]
6. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
7. The use of ambulatory blood pressure monitoring in managing hypertension according to different treatment guidelines.
Addison C; Varney S; Coats A
J Hum Hypertens; 2001 Aug; 15(8):535-8. PubMed ID: 11494091
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing white-coat effect.
Manios ED; Koroboki EA; Tsivgoulis GK; Spengos KM; Spiliopoulou IK; Brodie FG; Vemmos KN; Zakopoulos NA
Am J Hypertens; 2008 Feb; 21(2):153-8. PubMed ID: 18174883
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hypertension in acromegalic patients: clinical measurement versus 24-hour ambulatory blood pressure monitoring.
Minniti G; Moroni C; Jaffrain-Rea ML; Bondanini F; Gulino A; Cassone R; Tamburrano G
Clin Endocrinol (Oxf); 1998 Feb; 48(2):149-52. PubMed ID: 9579225
[TBL] [Abstract][Full Text] [Related]
10. The role of blood pressure variability in misdiagnosed clinic hypertension.
Cahan A; Ben-Dov IZ; Mekler J; Bursztyn M
Hypertens Res; 2011 Feb; 34(2):187-92. PubMed ID: 21068739
[TBL] [Abstract][Full Text] [Related]
11. White coat effect in treated hypertensive patients: sex differences.
Myers MG; Reeves RA
J Hum Hypertens; 1995 Sep; 9(9):729-33. PubMed ID: 8551486
[TBL] [Abstract][Full Text] [Related]
12. Twenty-four-hour autonomic nervous function in sustained and "white coat" hypertension.
Pierdomenico SD; Bucci A; Costantini F; Lapenna D; Cuccurullo F; Mezzetti A
Am Heart J; 2000 Oct; 140(4):672-7. PubMed ID: 11011344
[TBL] [Abstract][Full Text] [Related]
13. Clinical features, anthropometric characteristics, and racial influences on the 'white-coat effect' in a single-centre cohort of 1553 consecutive subjects undergoing routine ambulatory blood pressure monitoring.
Gualdiero P; Niebauer J; Addison C; Clark SJ; Coats AJ
Blood Press Monit; 2000 Apr; 5(2):53-7. PubMed ID: 10828890
[TBL] [Abstract][Full Text] [Related]
14. The importance of 24 hour ambulatory blood pressure monitoring after thoracic organ transplantation.
Walker AH; Locke TJ; Braidley PC; Al-Mohammed A
J Heart Lung Transplant; 2005 Nov; 24(11):1770-3. PubMed ID: 16297780
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of strategy for the detection of white coat hypertension based on ambulatory and home blood pressure monitoring.
Stergiou GS; Alamara CV; Skeva II; Mountokalakis TD
J Hum Hypertens; 2004 Feb; 18(2):85-9. PubMed ID: 14730322
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.
Ohkubo T; Kikuya M; Metoki H; Asayama K; Obara T; Hashimoto J; Totsune K; Hoshi H; Satoh H; Imai Y
J Am Coll Cardiol; 2005 Aug; 46(3):508-15. PubMed ID: 16053966
[TBL] [Abstract][Full Text] [Related]
17. Determinants of the white-coat effect in hypertensive subjects.
Mansoor GA; McCabe EJ; White WB
J Hum Hypertens; 1996 Feb; 10(2):87-92. PubMed ID: 8867561
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring.
Ben-Dov IZ; Ben-Arie L; Mekler J; Bursztyn M
Int J Cardiol; 2007 May; 117(3):355-9. PubMed ID: 16879886
[TBL] [Abstract][Full Text] [Related]
19. Does home blood pressure allow for a better assessment of the white-coat effect than ambulatory blood pressure?
Saladini F; Benetti E; Malipiero G; Casiglia E; Palatini P
J Hypertens; 2012 Nov; 30(11):2118-24. PubMed ID: 23027180
[TBL] [Abstract][Full Text] [Related]
20. White coat hypertension and white coat effect. Similarities and differences.
Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Zampi I; Gattobigio R; Sacchi N; Porcellati C
Am J Hypertens; 1995 Aug; 8(8):790-8. PubMed ID: 7576395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
